HSA
BMY icon

Hussman Strategic Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Hussman Strategic Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,000
Closed -$972K – 281
2025
Q2 		$972K Buy
+21,000
New +$1.03M 0.22% 144
2024
Q1 		– Sell
-31,500
Closed -$1.62M – 229
2023
Q4 		$1.62M Buy
+31,500
New +$1.65M 0.37% 114
2018
Q3 		– Sell
-25,000
Closed -$1.38M – 224
2018
Q2 		$1.38M Hold
25,000
– – 0.37% 116
2018
Q1 		$1.58M Buy
+25,000
New +$1.61M 0.44% 104

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hussman Strategic Advisors's BMY Position: Q3 2025 in Review

Hussman Strategic Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 21,000 shares — an estimated $972K sold.

Hussman Strategic Advisors first reported a position in BMY in Q1 2018 and held it in 4 quarters. The position peaked at $1.62M in Q4 2023. 2,276 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Hussman Strategic Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Hussman Strategic Advisors sold 21,000 Bristol-Myers Squibb shares in Q3 2025, an estimated $972K.
  • Hussman Strategic Advisors first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 4 quarters.
  • Hussman Strategic Advisors's Bristol-Myers Squibb position peaked at $1.62M in Q4 2023.
  • 2,276 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Hussman Strategic Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.